CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer-Reference-Cited by-同舟云学术

CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer

Published:2008-08-26 Issue:8 Volume:3 Page:e3062
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chrisanthar Ranjan,Knappskog Stian,Løkkevik Erik,Anker Gun,Østenstad Bjørn,Lundgren Steinar,Berge Elisabet O.,Risberg Terje,Mjaaland Ingvil,Mæhle Lovise,Engebretsen Lars Fredrik,Lillehaug Johan Richard,Lønning Per Eystein

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference78 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.;Lancet,2005

2. Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.;E Alba;J Clin Oncol,2004

3. Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance.;PE Lonning;Trends Mol Med,2004

4. retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.;AS Knoop;J Clin Oncol,2005

5. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.;M Tanner;J Clin Oncol,2006

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline variant profiling of CHEK2 sequencing variants in breast cancer patients;Cancer Genetics;2024-11

2. Impact of Molecular Profiling on Therapy Management in Breast Cancer;Journal of Clinical Medicine;2024-08-23

3. Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2;PLOS Genetics;2024-08-15

4. Comprehensive analysis of the functional impact of single nucleotide variants of humanCHEK2;2023-12-23

5. A Narrative Review of the <i>TP53</i> and Its Product the p53 Protein;OBM Genetics;2023-07-03